Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess Disease Pathology and Key Therapeutic Targets in Severe Asthma

NCT00327197 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00327197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00327197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess Disease Pathology and Key Therapeutic Targets in Severe Asthma
Lead sponsor
GlaxoSmithKline
Phase
Phase 1
Overall status
Terminated
Start date
August 2, 2005
Completion date
June 6, 2011
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma